SF99

As I have said Before, I think the design of BoM had weaknesses, but they did complete the study successfully, and this time the FDA will be supporting them. So in theory they could go it alone. I would definitely prefer them not to. It would be immensely better if a BP with the right experience took over. But they could do it. And I guess that's what matters in any negotiations.